|
Complete
your Medical Study in the UK. Medical College of London
is accepting new and transfer students to fill its
September 2002 and later classes. MCL is an affiliate
of the American International School of Medicine (AISM-UK)
and other Academic Institutions in the US and UK, with
innovative curriculum based on UK and USA standards
of medical education. Basic sciences completed at our
Central London Campus, and clinical sciences in the
USA, UK and other International locations. Both 4 and
6 year programs available. Contact Program Coordinator
Dr. Nasiri or Program Director Prof O. Tulp at Tel +44
1223 528 902, FAX +44 1223 529 545, or Email to: LCMTR.edu@ntlworld.com
Send mail inquiries to MCL Admissions, 28A Enniskillen
Road, Cambridge, UK CB4 1SQ. We will review your transcript
of previous medical education without obligation.
|
U.S.
Corporate Bond Market Uncertain Times
By
Scott B. MacDonald
We remain constructive about
the rest of the year for the corporate bond market, though
there are many uncertainties - the possibility of another
terrorist attack, the potential for a U.S. war against Iraq,
and a double-dip recession. Another al-Qaeda terrorist attack
on U.S. soil would be a blow to confidence, while it is difficult
to quantify the impact of a U.S. war against Iraq. A double-dip
recession would obviously be a big negative. Although we do
not rule out a double dip recession, we expect the U.S. economy
to muddle through. The combination of auto sales, mortgage
refinancing, and housing, plus one more Fed interest rate
cut, will allow the economy to slide by at around 2.5% for
2002. That stated, we still expect investors to remain very
sensitive to any negative news on the economy and to remain
focused on corporate earnings (in late September and October
for Q3). The equity market will continue to be exceedingly
volatile, with seismic-like daily shifts.
Much depends on restoring investor confidence. In August,
when we enjoyed a short-lived equity market rally, the corporate
bond market saw spread tightening and new issuance. During
the third week of August, 28 issuers came forward and brought
$16.36 billion in bonds to market, the largest weekly number
since March 2002s $26.9 billion. While some economic
numbers helped nudge the rally, there was also a sense of
relief that most major companies made it through the August
14th CEO and CFO earnings accountability signings without
major problems. Indeed, the corporate governance issue, barring
any new scandals, is likely to fade as a concern.
It is estimated that potential new investment grade corporate
bond issuance for the remaining months of 2002 could be between
$90-$100 billion, at least part of which comes from the need
to refinance as debt comes due. The next major trigger for
the corporate bond market is likely to be Q3 corporate earnings,
which start in late September. As corporate governance issues
fade, attention will return to more fundamental credit concerns
about profitability, debt management, and liquidity. Related
to this is the pace of the economy. Most economists are looking
for real GDP growth in Q3 in excess of 3%, followed a slower
pace in Q4. That could help provide some traction for better
corporate earnings through the end of the year. However, there
remains considerable nervousness in corporate America and
most managers are still looking to trim capital spending --
not increase it. The earnings announcements of the large brokerages,
such as Morgan Stanley, thus far have not set a positive tone.
JPMorgan Chases problems, including ratings downgrades,
have not helped.
It should also be understood that the drop in U.S. unemployment
from 5.9% to 5.7% was largely due to job creation in government,
while manufacturing actual had a drop in employment. As we
see consumer demand remaining in positive territory, the most
likely outcome is that the economy on a whole will not get
much worse, but it will not get much better. The same can
be said for the corporate bond market.
(click
here to return to the table of contents)
Editor: Dr. Scott B. MacDonald, Sr. Consultant
Deputy Editor: Dr. Jonathan Lemco, Director and Sr. Consultant
Associate Editors: Robert Windorf, Darin Feldman
Publisher: Keith W. Rabin, President
Web Design: Michael Feldman, Sr. Consultant
Contributing Writers to this Edition: Scott B. MacDonald, Keith W. Rabin, Uwe Bott, Jonathan Lemco, Jim Johnson, Andrew Novo, Joe Moroney, Russell Smith, and Jon Hartzell
|